ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2025; 15(8): 185-198


Advancements and applications of COX inhibitors: A detailed bibliometric analysis of trending topics and emerging themes

Razan Naji, Zeinah Almulhim, Yassir A. Almofti, Maryam Mahmoud, Mahmoud kandeel.



Abstract
Download PDF Post

Cyclooxygenase (COX) inhibitors are an important aspect of pain and inflammation therapy. This study provides a comprehensive bibliometric analysis of COX inhibitor research in order to identify key patterns, themes, emerging topics, authors, journals, and worldwide collaboration networks. The Scopus database was used to search for research on COX inhibitors from inception to 2024. The study themes, co-authorship networks, citation patterns, and publication growth were analyzed using R bibliometric tools such as Bibliometrix and VOSviewer. The findings show a 17.82% rate of international collaboration among the 3,400 publications examined, which came from 1,219 journals and were produced by 13,993 authors. The annual growth in research production was 4.15 percent. Celecoxib and molecular docking were frequently referenced, and the research was primarily concerned with inflammation, cancer prevention, and COX-2 inhibition. The evolution of trend topics can be summarized as follows: from early 2000s foundational pharmacological investigations to mid-2000s selective COX-2 inhibitors with reduced side effects. Computational techniques like molecular docking, 3D-QSAR, and statistical approaches have lately gained popularity for optimizing drug discovery. COX inhibitor research is expected to focus on using AI-driven drug discovery to develop more selective and less hazardous drugs.

Key words: Cyclooxygenase Inhibitors, COX-2, Bibliometric Analysis, Nonsteroidal Anti-inflammatory Drugs, Celecoxib.







Bibliomed Article Statistics

42
31
17
21
17
18
22
5
R
E
A
D
S

28

14

24

8

15

13

25

2
D
O
W
N
L
O
A
D
S
0708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.